Bacterial Infections
📧 Sign up to get email alerts when something new happens for Bacterial Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA. a Prospective Study Will Evaluate the Performance of Direct LS-TA in Triage Febrile Patients Into Major Categories of Infections: Viral, Bacterial or Active Tuberculosis.
A prospective study from The Chinese University of Hong Kong will evaluate Direct LS-TA using leukocyte single-cell gene expression to triag…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Use of Fosfomycin in the Treatment of Bacterial Infections
A clinical trial investigating intravenous fosfomycin for bacterial infections, analyzing medical records of patients treated with IV fosfom…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: VAT-2: Evaluation of a Virtual Antimicrobial Stewardship Team (VAT) on Antibiotic Prescriptions in Nursing Homes [NA]
A completed clinical trial evaluating VAT-2, a Virtual Antimicrobial Stewardship Team, and its effect on antibiotic prescribing in nursing h…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection [Phase 1]
Phase 1 pharmacokinetic study of LP-001 in children with bacterial infections has completed.
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Host Immunity, Plasmodium and Pathogens Co-Infections [NA]
Clinical trial from Institut Pasteur studying host immunity in Plasmodium infection and bacterial co-infections; not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100 [Phase 1]
A Phase 1 study sponsored by BioVersys AG evaluated rifabutin lung penetration after multiple intravenous administrations of BV100. The tria…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Safety of Intravenous Apramycin in Adults [Phase 1]
A Phase 1 safety study of intravenous apramycin in adults has completed, with results posted in December 2024.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Therapeutic Drug Monitoring - Targeting IMproved Effectiveness
A completed clinical trial evaluating therapeutic drug monitoring aimed at improving effectiveness in pneumonia and sepsis due to bacterial …
-
FDA approval · 2024-11-19FDA Approved: ERYTHROMYCIN LACTOBIONATE — Original Application (Gland Pharma Limited)
FDA approved the original application for erythromycin lactobionate from Gland Pharma Limited (ANDA216761). This marks the approval of a gen…
-
CLINICAL_TRIALS other · 2024-10-01Clinical Trial Update: A Cluster Randomized Controlled Trial to Compare the Rate of Antibiotic Infusion [NA]
This clinical trial entry describes a cluster randomized study comparing antibiotic infusion rates for acute upper respiratory tract infecti…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in Infected Patients With Cirrhosis (SURVIC_STUDY) [Phase 4]
A Phase 4 trial comparing conventional antibiotic strategies versus regimens guided by epidemiological surveillance in patients with decompe…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Impact of Procalcitonin-guided Algorithm on Early Discontinuation of Antibiotic Therapy [NA]
This clinical study evaluates whether a procalcitonin-guided algorithm can enable earlier discontinuation of antibiotic therapy in bacterial…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Antibiotic Dosing in Geriatric Patients At the Emergency Department
A clinical trial update describes a study evaluating antibiotic dosing strategies for geriatric patients presenting to the emergency departm…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome [Phase 1]
Phase 1 clinical trial investigating absorption of antibiotics with high oral bioavailability in patients with Short Bowel Syndrome; current…
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Development and Evaluation of AI Program for Predicting Bacterial Species From Urine Gram Stain Specimens
GramEye is developing and evaluating an AI program to predict bacterial species from urine Gram stain images; the trial is currently recruit…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD [NA]
A pilot study to test a remotely delivered intensive outpatient program for individuals with opioid use disorder. The study is currently rec…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Prospective Study on Febrile Batteries in Pediatric Oncohaematological Patients (SuBiTo)
A prospective study called SuBiTo on febrile episodes in pediatric oncohematology patients is currently active but not recruiting. The trial…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Molecular Biomarkers for Sepsis
A University Hospital Basel study evaluating molecular biomarkers for sepsis, including severe community-acquired pneumonia, has been termin…
-
EMA approval · 2024-04-03EMA Authorised: Ertapenem SUN (ertapenem sodium) — SUN Pharmaceutical Industries (Europe) B.V.
The EMA authorised Ertapenem SUN (ertapenem sodium) by SUN Pharmaceutical Industries (Europe) B.V. for bacterial infections.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) [Phase 3]
Phase III clinical trial of a candidate PCV13 vaccine in healthy individuals aged 6 weeks and above has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® [Phase 1, Phase 2]
Phase 1/2 clinical trial update for DUOFAG assessing safety and efficacy in various bacterial infections including surgical site and Staphyl…
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Effect of PreforPro® on Urinary and Vaginal Health [Phase 3]
Phase 3 clinical trial update for PreforPro® evaluating urinary and vaginal health, with conditions including bacterial vaginosis and vagina…
-
FDA approval · 2023-01-20FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (HIKMA PHARMACEUTICALS USA INC.)
FDA approved vancomycin hydrochloride from Hikma Pharmaceuticals USA as an original application, introducing a new antimicrobial product. Th…
-
CLINICAL_TRIALS trial_result · 2022-11-28Clinical Trial Update: Pharmacokinetics of Colistin in Critically-ill Patients With AKI Who Receive SLED [Phase 4]
Phase 4 trial assessing pharmacokinetics of colistin in critically ill patients with acute kidney injury undergoing sustained low-efficiency…
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM) [Phase 2]
Phase 2 clinical trial update on MRSA bactericidal gel (Vancogel) for challenging skin and soft tissue infections.